ADCC-Enhanced Cell Line Development_Hangzhou Healsun Biopharm Co.,Ltd.

Cell Line with High Expression ADCC-Enhanced Cell Line Development Commercially Licensable Host Cells

ADCC-Enhanced Cell Line Development

HaoYue Fut8 Knockout Cell Line Platforms is developed from commercially licensable CHO-K1 host cells. This platform enables the generation of homogeneous and stable low-fucosylation modified cell lines through transfection and screening, resulting in enhanced ADCC (Antibody-Dependent Cell-Mediated Cytotoxicity) effects.

Building on the foundation of the HaoYue platform, we have further developed a Fut8 knockout ADCC-enhanced stable cell line construction platform.

Email：healsunbd@hs-biopharm.com

Early-Stage
Biologics ADC Protein Store
CMC Process
Cell Line Development Biologics Process Development ADC Process Development Analytical Support
GMP Pilot Production
Biologics ADC
Commercial Production
PC/PV Commercial Production
CGT
Exosome mRNA AAV
Biosimilars
Biosimilars
About Us
Company Profile Contact Us

Cell Line with High Expression ADCC-Enhanced Cell Line Development Commercially Licensable Host Cells

ADCC-Enhanced Cell Line Development

Early-Stage

CMC Process

GMP Pilot Production

Commercial Production

CGT

Biosimilars

About Us